Pycnogenol® Offers Clinically Backed Cognitive Support Across Generations

Skip to Content News Archives Economy Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeGlobeNewswireThis section is The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire Pycnogenol® Offers Clinically Backed Cognitive Support Across GenerationsAuthor of the article:An infographic depicting Pycnogenol's cognitive benefits. GNWResearch on French maritime pine bark extract spans children, students, working professionals and older adults looking to stay mentally sharpTHIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountGENEVA, Sept. 23, 2026 (GLOBE NEWSWIRE) — Brain health is no longer a concern reserved for older adults. Children are navigating attention challenges, students are managing demanding academic schedules, working parents are balancing competing priorities, and older adults want to maintain memory and mental alertness. Consumer interest is growing alongside these everyday demands: the global cognitive supplements market is projected to grow from $7.48 billion in 2025 to $13.92 billion by 2034.As consumers seek natural, research-backed ways to support focus, memory and mental performance, Pycnogenol®, a standardized French maritime pine bark extract, brings more than 40 years of scientific research to the conversation. An extensively researched natural ingredient, Pycnogenol® has been studied in more than 160 clinical trials and is supported by 450 scientific publications across a wide range of health applications. Its cognitive research is particularly notable for spanning multiple generations and stages of life.Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againChildren: In a 10-week double-blind, randomized clinical trial of 88 children with ADHD, Pycnogenol® was studied alongside methylphenidate and placebo. Teacher assessments found significant improvements in overall ADHD symptoms and hyperactivity/impulsivity among children taking Pycnogenol® compared with placebo. The study also found that adverse effects were reported five times more frequently with methylphenidate than with Pycnogenol®.Students: In an eight-week observational study of healthy students ages 18 to 27, Pycnogenol® supplementation was associated with improvements in attention, memory and other measures of mental performance. Academic test scores were also 7.6% better among supplemented students compared with controls.Working professionals: In a 12-week study of healthy professionals ages 35 to 55 with increased oxidative stress, Pycnogenol® supplementation was associated with improvements in cognitive function, sustained attention, memory, executive function and mood. Researchers also reported improvements across everyday professional tasks, alongside a 30.4% reduction in oxidative stress.Older adults: A double blind, placebo-controlled trial with 101 adults ages 60 to 85 with moderate decline of their cognitive function investigated the effects of Pycnogenol® for 3 months on mental performance. Statistically significant improvements with Pycnogenol®, as compared to the placebo group were found for memory-based cognitive functions, more precisely the spatial and numeric working memory. The blood profiles showed a significant decrease of lipid peroxidation products after Pycnogenol® intake, confirming Pycnogenol®’s role as a potent antioxidant.“People often don’t start thinking seriously about cognitive health until they’re older, but focus, memory and mental stamina matter much earlier in life,” said renowned natural physician and author, Dr. Fred Pescatore. “As a physician, I’m always looking for approaches that are supported by clinical research, not just trends. That’s what I find compelling about Pycnogenol®. It has been studied across different age groups and in areas like attention, memory and mental performance, giving people a science-backed way to think about supporting cognitive wellness over time.”What makes Pycnogenol® particularly relevant to cognitive health is the way its broader physiological effects may support brain function. Research suggests that Pycnogenol® supports endothelial function and healthy nitric oxide production, helping promote healthy blood flow and the delivery of oxygen and nutrients throughout the body. It has also demonstrated antioxidant and anti-inflammatory activity in published studies—mechanisms that are increasingly important in conversations around maintaining cognitive performance and mental well-being.This advertisement has not loaded yet.This advertisement has not loaded yet, but your article continues below.Derived from the bark of French maritime pine trees grown in sustainably managed forests in southwest France, Pycnogenol® is a standardized combination of procyanidins, bioflavonoids and phenolic acids. Its extensive body of research spans cognitive health as well as cardiovascular health, skin health, joint function and women’s health.To learn more about Pycnogenol® and find products containing the ingredient, visit www.pycnogenol.com.Horphag Research is the exclusive worldwide distributor for Pycnogenol® (pic-noj-en-all) brand French maritime pine bark extract. Pycnogenol® is a registered trademark of Horphag Research. For its patented ingredient, Pycnogenol®, Horphag Research has been awarded the Frost & Sullivan Excellence in Research Award, Nutraceutical Business & Technology Safety & Quality Award, SupplySide West Scientific Excellence Award and The American Botanical Council’s Tyler Research Award. Horphag Research has the exclusive rights to market and sell Pycnogenol® worldwide and benefits from more than 40 years of scientific research assuring the safety and efficacy of Pycnogenol® as a dietary supplement.Media Contact: Heather Tidwell horphag@mww.comNotice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.